Drug
Isotretinoin
Isotretinoin: highest development phase Phase 2, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Isotretinoin NCT04154293 | Phase 2 | Congenital Ichthyosis |
Latest
No recent events.
Follow Isotretinoin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.